新型分子特征可选择性预测结肠癌的临床结局。
Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer.
作者信息
Lahorewala Sarrah, Panda Chandramukhi S, Aguilar Karina, Morera Daley S, Zhu Huabin, Gramer Adriana L, Bhuiyan Tawhid, Nair Meera, Barrett Amanda, Bollag Roni J, Lokeshwar Vinata B
机构信息
Departments of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Department of Pathology Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
出版信息
Cancers (Basel). 2025 Mar 7;17(6):919. doi: 10.3390/cancers17060919.
Abstract
Among the 152,810 estimated new cases of adenocarcinoma of the colon (COAD) and the rectum (READ) in 2024, the rates of colorectal cancer (CRC) are increasing in young adults (age < 55 years) [...].
摘要
在2024年估计的152,810例结肠癌（COAD）和直肠癌（READ）新发病例中，年轻成年人（年龄<55岁）的结直肠癌（CRC）发病率正在上升[...]。
Zotero 插件